What Should an Ideal Vaccine Postlicensure Safety System Be?

被引:22
作者
Griffin, Marie R. [1 ,2 ,3 ,4 ]
Braun, M. Miles [5 ]
Bart, Kenneth J. [6 ]
机构
[1] Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37212 USA
[2] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA
[3] Mid S Geriatr Res Educ & Clin Ctr, Nashville, TN USA
[4] VA Tennessee Valley Healthcare Syst, Clin Res Ctr Excellence, Nashville, TN USA
[5] US FDA, Off Biostat & Epidemiol, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA
[6] Off Secretary Hlth & Human Serv, Natl Vaccine Program Off, Off Publ Hlth & Sci, Washington, DC USA
基金
美国医疗保健研究与质量局;
关键词
ADVERSE EVENTS; UNITED-STATES; ASSOCIATION; LICENSURE; MEASLES; AUTISM; MUMPS;
D O I
10.2105/AJPH.2008.143081
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In 2007 the National Vaccine Program, along with the Centers for Disease Control and Prevention, the Food and Drug Administration, the National Institutes of Health, and the Health Resources and Services Administration, sponsored a public conference titled "Vaccine Safety Evaluation: Post Marketing Surveillance "The objective was to discuss enhanced approaches to postlicensure evaluation of vaccine safety, including active and passive surveillance systems and special studies. The conference participants reviewed the evolution of the assessment of vaccine safety, detailed current national approaches to postmarketing safety, and offered new approaches to evaluating vaccine safety. A number of the participants recommended that information systems be expanded to include reliable information on vaccination and health outcomes in large populations. We summarize the major meeting presentations and discussions. (Am J Public Health. 2009;99:S345-S350. doi.10.2105/AJPH.2008.143081)
引用
收藏
页码:S345 / S350
页数:6
相关论文
共 25 条
[21]   CUTTER INCIDENT - POLIOMYELITIS FOLLOWING FORMALDEHYDE-INACTIVATED POLIOVIRUS VACCINATION IN UNITED STATES DURING SPRING OF 1955 .1. BACKGROUND [J].
NATHANSON, N ;
LANGMUIR, AD .
AMERICAN JOURNAL OF HYGIENE, 1963, 78 (01) :16-+
[22]  
O'Hallahan Jane, 2004, Pediatr Infect Dis J, V23, pS293
[23]  
Verstraeten Thomas, 2003, Expert Rev Vaccines, V2, P21, DOI 10.1586/14760584.2.1.21
[24]  
2006, MMWR MORB MORTAL WKL, V55, P1120
[25]  
2002, MMWR MORB MORTAL WKL, V51, P760